These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28144709)

  • 21. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets.
    Utsugisawa K; Kizawa H; Nagane Y; Kondoh R; Iwa Y; Akutsu H; Tohgi H; Terayama Y
    Thromb Haemost; 2005 Nov; 94(5):1012-8. PubMed ID: 16363245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
    Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
    Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.
    Rong R; Hu G; Wang W; Muroya Y; Miura T; Ogawa Y; Kohzuki M; Ito O
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():80-86. PubMed ID: 30227249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.
    Hakam AC; Hussain T
    Hypertension; 2005 Feb; 45(2):270-5. PubMed ID: 15596573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
    Saitoh Y; Hongwei W; Ueno H; Mizuta M; Nakazato M
    Diabetes Res Clin Pract; 2010 Oct; 90(1):54-9. PubMed ID: 20667613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-α inhibits angiotensin II receptor type 1 expression in dorsal root ganglion neurons via β-catenin signaling.
    Yang Y; Wu H; Yan JQ; Song ZB; Guo QL
    Neuroscience; 2013 Sep; 248():383-91. PubMed ID: 23806715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
    Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
    Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.
    Müller-Fielitz H; Lau M; Geißler C; Werner L; Winkler M; Raasch W
    Br J Pharmacol; 2015 Feb; 172(3):857-68. PubMed ID: 25258168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
    Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S101-3. PubMed ID: 9892149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
    Castejon AM; Zollner E; Tristano AG; Cubeddu LX
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
    Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
    Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II.
    Yasuda N; Akazawa H; Qin Y; Zou Y; Komuro I
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):393-9. PubMed ID: 18046542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse.
    Bivalacqua TJ; Dalal A; Lambert DG; Champion HC; Kadowitz PJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S98-100. PubMed ID: 9892148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
    Chipitsyna G; Gong Q; Gray CF; Haroon Y; Kamer E; Arafat HA
    Endocrinology; 2007 May; 148(5):2198-208. PubMed ID: 17303665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure.
    Zong WN; Yang XH; Chen XM; Huang HJ; Zheng HJ; Qin XY; Yong YH; Cao K; Huang J; Lu XZ
    Acta Pharmacol Sin; 2011 Nov; 32(11):1345-50. PubMed ID: 21963897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.
    Sánchez-Lemus E; Benicky J; Pavel J; Larrayoz IM; Zhou J; Baliova M; Nishioku T; Saavedra JM
    Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1376-84. PubMed ID: 19225144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.